Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
11.72
+0.52 (4.64%)
At close: Sep 17, 2026, 4:00 PM EDT
11.77
+0.05 (0.43%)
After-hours: Sep 17, 2026, 6:29 PM EDT
Kura Oncology Employees
Kura Oncology had 260 employees as of December 31, 2025. The number of employees increased by 68 or 35.42% compared to the previous year.
Employees
260
Change (1Y)
68
Growth (1Y)
35.42%
Revenue / Employee
$297,019
Profits / Employee
-$1,141,442
Market Cap
1.04B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sana Biotechnology | 142 |
| MoonLake Immunotherapeutics | 130 |
| Janux Therapeutics | 113 |
| Adlai Nortye Group | 109 |
| Odyssey Therapeutics | 100 |
| Cybin | 100 |
| Apnimed | 81 |
| Inventiva | 77 |
KURA News
- 1 day ago - Kura Oncology Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 8 days ago - Kura Oncology Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 8 days ago - Kura Oncology launches Caspian Therapeutics - TheFly
- 8 days ago - Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes - GlobeNewsWire
- 9 days ago - Kura Oncology Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 9 days ago - Kura Oncology appoints Jennifer Fulk as CFO - TheFly
- 9 days ago - Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer - GlobeNewsWire
- 13 days ago - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire